INTERNATIONAL PATENT: FLARE THERAPEUTICS INC. FILES APPLICATION FOR "PYRIDO[3,2-B]INDOLE-3-CARBONITRILE COMPOUNDS AND COMPOSITION FOR TARGETING TP53-Y220C MUTANTS"

GENEVA, July 21 -- FLARE THERAPEUTICS INC. (215 First Street, Suite 440Cambridge, MA 02142) filed a patent application (PCT/US2025/010797) for "PYRIDO[3,2-B]INDOLE-3-CARBONITRILE COMPOUNDS AND COMPOSITION FOR TARGETING TP53-Y220C MUTANTS" on Jan 08, 2025. With publication no. WO/2025/151549, the details related to the patent application was published on Jul 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WILSON, Jonathan E. (6 Cottage AvenueArlington, MA 02474)

Abstract: Provided are compounds of Formula (I): and pharmaceutically acceptable salts and compositions thereof, which are us...